Chikungunya virus, risks and responses for Australia by Andreas Suhrbier, Greg Devine

Connect to this object online.

Poxvirus-based vector systems and the potential for multi-valent and multi-pathogen vaccines by Natalie A. Prow, Rocio Jimenez Martinez, John D. Hayball, Paul M. Howley, Andreas Suhrbier

Connect to this object online.

Effective chikungunya virus-like particle vaccine produced in insect cells. by Stefan W Metz, Joy Gardner, Corinne Geertsema, Thuy T Le, Lucas Goh, Just M Vlak, Andreas Suhrbier, Gorben P Pijlman

Connect to this object online.

Multiple immune factors are involved in controlling acute and chronic chikungunya virus infection. by Yee Suan Poo, Penny A Rudd, Joy Gardner, Jane A C Wilson, Thibaut Larcher, Marie-Anne Colle, Thuy T Le, Helder I Nakaya, David Warrilow, Richard Allcock, Helle Bielefeldt-Ohmann, Wayne A Schroder, Alexander A Khromykh, José A Lopez, Andreas Suhrbier

Connect to this object online.

A neutralizing monoclonal antibody targeting the acid-sensitive region in chikungunya virus E2 protects from disease. by Suganya Selvarajah, Nicole R Sexton, Kristen M Kahle, Rachel H Fong, Kimberly-Anne Mattia, Joy Gardner, Kai Lu, Nathan M Liss, Beatriz Salvador, David F Tucker, Trevor Barnes, Manu Mabila, Xiangdong Zhou, Giada Rossini, Joseph B Rucker, David Avram Sanders, Andreas Suhrbier, Vittorio Sambri, Alain Michault, Marcus O Muench, Benjamin J Doranz, Graham Simmons

Connect to this object online.